Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#117 / 117 Total
INVA - Innoviva Inc - Stock Price Chart
CompanyInnoviva Inc
Market Cap945.97MEPS (ttm)0.44
P/E33.41EPS this Y-29.54%
Forward P/E18.00EPS next Y-50.90%
PEG1.73EPS past 5Y15.22%
P/S3.11EPS next 5Y19.34%
P/B1.51EPS Q/Q-64.89%
Dividend-Sales Q/Q0.00%
Insider Own1.09%Inst Own108.71%
Insider Trans0.58%Inst Trans-2.65%
Short Float15.16%EarningsNov 01/a
Analyst Recom3.00Target Price15.00
Avg Volume717.65K52W Range10.64 - 14.77
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zhen MarianneChief Accounting OfficerNov 15Sale13.9910,994153,81040,158Nov 17 04:30 PM
DENNER ALEXANDER J10% OwnerJun 06Buy13.058,000104,3847,215,000Jun 07 08:10 PM
DENNER ALEXANDER J10% OwnerJun 05Buy13.047,00091,2977,207,000Jun 07 08:10 PM
DENNER ALEXANDER J10% OwnerMay 30Buy13.01120,0001,560,6487,200,000May 30 07:01 PM
DENNER ALEXANDER J10% OwnerMay 26Buy13.1230,000393,7297,080,000May 30 07:01 PM